Furthermore, elevated CDC6 expression may promote tumor cell proliferation by regulating the cell cycle (Borlado and Méndez, 2008), while high LCK expression may enhance T cell activity, thereby improving immunotherapy efficacy (Moogk et al., 2016). The gene discussed is LCK; the disease is neoplasm.